Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Our lead programs and unique approach are unlocking the therapeutic potential of historically undruggable targets in human diseases.
Location: United States, Massachusetts, Woburn
Member count: 11-50
Total raised: $52M
Founded date: 2018
Investors 2
| Date | Name | Website |
| 12.01.2023 | Korea Inve... | partners.k... |
| - | Vivo Capit... | vivocapita... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 30.11.2022 | Series A | $52M | - | finsmes.co... |
Mentions in press and media 12
| Date | Title | Description | Category | Author | Source |
| 30.11.2022 | Cambridge-... | CAMBRIDGE, Mass., Nov. 29, 202... | - | - | vcbay.news... |
| 29.11.2022 | Rgenta The... | CAMBRIDGE, MA, Rgenta Therap... | - | - | vcnewsdail... |
| 29.11.2022 | Rgenta The... | What You Should Know: Only a ... | - | Fred Penni... | hitconsult... |
| 29.11.2022 | Rgenta The... | Rgenta Therapeutics, a Cambrid... | USA | - | finsmes.co... |
| 26.05.2021 | China Dige... | China-headquartered Lilly Asia... | - | Liya Su | dealstreet... |
| 26.05.2021 | China Dige... | Premium China-headquartered L... | - | Liya Su | dealstreet... |
| 25.05.2021 | Rgenta The... | CAMBRIDGE, Mass., May 25, 2021... | - | - | marketscre... |
| 25.05.2021 | Rgenta The... | CAMBRIDGE, Mass., May 25, 20... | - | - | prnewswire... |
| 04.04.2020 | Rgenta The... | CAMBRIDGE, MA, Rgenta Therap... | - | - | vcnewsdail... |
| 02.04.2020 | Rgenta The... | Rgenta Therapeutics, a new bio... | - | - | citybizlis... |
Show more